Medical management of glaucoma: focus on ophthalmologic drug delivery systems of timolol maleate
Open Access
- 22 March 2016
- journal article
- review article
- Published by Taylor & Francis in Artificial Cells, Nanomedicine, and Biotechnology
- Vol. 45 (3) , 448-459
Abstract
Eye is a vital organ of our body and any complication not only poses the risk of serious medical condition but also economic burden on the individual. Timolol maleate is one of the preferable therapeutic agents for the management of glaucoma. Globally, eye drops are among the most common and popular conventional formulations, but they are also associated with some limitations in terms of therapeutic response, bioavailability, dosing frequency and poor patient compliance. Present paper gives an overview of the drug delivery systems developed for management of glaucoma, advances and novel approaches with special emphasis on timolol drug delivery.Keywords
This publication has 58 references indexed in Scilit:
- Sustained delivery of timolol maleate from poly(lactic-co-glycolic acid)/poly(lactic acid) microspheres for over 3 monthsJournal of Microencapsulation, 2008
- Poly(N-isopropylacrylamide)–chitosan as thermosensitive in situ gel-forming system for ocular drug deliveryJournal of Controlled Release, 2007
- Chitosan Nanoparticles for Prolonged Delivery of Timolol MaleateDrug Development and Industrial Pharmacy, 2007
- Improved pharmacodynamics of timolol maleate from a mucoadhesive niosomal ophthalmic drug delivery systemInternational Journal of Pharmaceutics, 2005
- Carrageenan–gelatin mucoadhesive systems for ion-exchange based ophthalmic delivery: in vitro and preliminary in vivo studiesEuropean Journal of Pharmaceutics and Biopharmaceutics, 2004
- Soft Contact Lenses Capable of Sustained Delivery of TimololJournal of Pharmaceutical Sciences, 2002
- Xyloglucan as a Novel Vehicle for Timolol: Pharmacokinetics and Pressure Lowering Activity in RabbitsJournal of Ocular Pharmacology and Therapeutics, 2000
- Ophthalmic drug delivery systems—Recent advancesProgress in Retinal and Eye Research, 1998
- Ocular-Specific Delivery of Timolol by Sequential Bioactivation of its Oxime and Methoxime AnalogsJournal of Ocular Pharmacology and Therapeutics, 1997
- The Kinetics of Timolol in the Rabbit Lens: Implications for Ocular Drug DeliveryPharmaceutical Research, 1989